Understanding human glycosylation disorders: Biochemistry leads the charge

Journal of Biological Chemistry

Volumn 288, Issue 10, 2013, Pages 6936-6945

  Freeze, Hudson H ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC SCIENCE; BIOCHEMICAL ANALYSIS; CANDIDATE GENES; DIAGNOSTIC MARKERS; MULTIPLE PATHWAYS; NEXT-GENERATION SEQUENCING; ORGAN SYSTEMS; RESEARCH OPPORTUNITIES;

ESTERIFICATION;

GLYCOSYLATION;

BIOLOGICAL MARKER; GLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; MANNOSE; N ACETYLGALACTOSAMINE; SUGAR; TRANSFERRIN;

BIOCHEMISTRY; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; ENDOPLASMIC RETICULUM STRESS; EXOME; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GLUCOSE METABOLISM; GLYCOSYLATION; HUMAN; MOLECULAR PATHOLOGY; MUSCULAR DYSTROPHY; MYASTHENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; WALKER WARBURG SYNDROME;

CONGENITAL DISORDERS OF GLYCOSYLATION; EXOME; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; HYPOGLYCEMIA; LIVER; MANNOSYLTRANSFERASES; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 84874901762     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R112.429274     Document Type: Review

References (82)

1. Matthijs, G., Rymen, D., Millón, M. B., Souche, E., and Race, V. (2013) Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG. Glycoconj. J. 30, 67-76
2. Saunders, C. J., Miller, N. A., Soden, S. E., Dinwiddie, D. L., Noll, A., Alnadi, N. A., Andraws, N., Patterson, M. L., Krivohlavek, L. A., Fellis, J., Humphray, S., Saffrey, P., Kingsbury, Z., Weir, J. C., Betley, J., Grocock, R. J., Margulies, E. H., Farrow, E. G., Artman, M., Safina, N. P., Petrikin, J. E., Hall, K. P., and Kingsmore, S. F. (2012) Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4, 154ra135
3. de Ligt J., Willemsen, M. H., van Bon, B. W., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., del Rosario, M., Hoischen, A., Scheffer, H., de Vries, B. B., Brunner, H. G., Veltman, J. A., and Vissers, L. E. (2012) Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921-1929
4. Mefford, H. C. (2012) Diagnostic exome sequencing-are we there yet? N. Engl. J. Med. 367, 1951-1953
5. Committee on Assessing the Importance and Impact of Glycomics and Glycosciences, Board on Chemical Sciences and Technology, Board on Life Sciences, Division on Earth and Life Studies, and National Research Council (2012) Transforming Glycoscience: A Roadmap for the Future, The National Academies Press, Washington, D.C.
6. Hu, H., Eggers, K., Chen, W., Garshasbi, M., Motazacker, M. M., Wrogemann, K., Kahrizi, K., Tzschach, A., Hosseini, M., Bahman, I., Hucho, T., Mühlenhoff, M., Gerardy-Schahn, R., Najmabadi, H., Ropers, H. H., and Kuss, A. W. (2011) ST3GAL3 mutations impair the development of higher cognitive functions. Am. J. Hum. Genet. 89, 407-414
7. Freeze, H. H., Eklund, E. A., Ng, B. G., and Patterson, M. C. (2012) Neurology of inherited glycosylation disorders. Lancet Neurol. 11, 453-466
8. Hennet, T. (2012) Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim. Biophys. Acta 1820, 1306-1317
9. Freeze, H. H., and Haltiwanger, R. S. (2009) in Essentials of Glycobiology (Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., and Bertozzi, C. R., eds) 2nd Ed., pp. 162-170, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
10. Freeze, H. H., and Elbein, A. D. (2009) in Essentials of Glycobiology Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., and Bertozzi, C. R., eds) 2nd Ed., pp. 47-61, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
11. Ferguson, M. A. J., Kinoshita, T., and Hart, G. W. (2009) in Essentials of Glycobiology Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., and Bertozzi, C. R., eds) 2nd Ed., pp. 143-161, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
12. Muntoni, F., Torelli, S., and Brockington, M. (2008) Muscular dystrophies due to glycosylation defects. Neurotherapeutics 5, 627-632
13. Stalnaker, S. H., Stuart, R., and Wells, L. (2011) Mammalian O-mannosylation: Unsolved questions of structure/function. Curr. Opin. Struct. Biol. 21, 603-609
14. Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M. E., Yu, L., and Campbell, K. P. (2012) Dystroglycan function requires xylosyl-and glucuronyltransferase activities of LARGE. Science 335, 93-96
15. Yoshida-Moriguchi, T., Yu, L., Stalnaker, S. H., Davis, S., Kunz, S., Madson, M., Oldstone, M. B., Schachter, H., Wells, L., and Campbell, K. P. (2010) O-Mannosyl phosphorylation of α-dystroglycan is required for laminin binding. Science 327, 88-92
16. Amberger, J., Bocchini, C., and Hamosh, A. (2011) A new face and new challenges for Online Mendelian Inheritance in Man (OMIM(R)). Hum. Mutat. 32, 564-567
17. Aebi, M., Helenius, A., Schenk, B., Barone, R., Fiumara, A., Berger, E. G., Hennet, T., Imbach, T., Stutz, A., Bjursell, C., Uller, A., Wahlstrom, J. G., Briones, P., Cardo, E., Clayton, P., Winchester, B., Cormier-Dalre, V., de Lonlay, P., Cuer, M., Dupré, T., Seta, N., de Koning, T., Dorland, L., de Loos, F., Kupers, L., et al. (1999) Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: An updated nomenclature for CDG. Glycoconj. J. 16, 669-671 (Pubitemid 30598893)
18. Jaeken, J., Hennet, T., Matthijs, G., and Freeze, H. H. (2009) CDG nomenclature: Time for a change! Biochim. Biophys. Acta 1792, 825-826
19. Brockington, M., Torelli, S., Sharp, P. S., Liu, K., Cirak, S., Brown, S. C., Wells, D. J., and Muntoni, F. (2010) Transgenic overexpression of LARGE inducesα-dystroglycan hyperglycosylation in skeletal and cardiac muscle. PLoS ONE 5, e14434
20. Ng, B. G., Hackmann, K., Jones, M. A., Eroshkin A. M., He, P., Wiliams, R., Bhide, S., Cantagrel, V., Gleeson, J. G., Paller, A. S., Schnur, R. E., Tinschert, S., Zunich, J., Hegde, M. R., and Freeze, H. H. (2012) Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am. J. Hum. Genet. 90, 685-688
21. O'Brien, J. F., Lacey, J. M., and Bergen, H. R., 3rd (2007) Detection of hypo-N-glycosylation using mass spectrometry of transferrin. Curr. Protoc. Hum. Genet. Chapter 17, Unit 17.14
22. Sturiale, L., Barone, R., and Garozzo, D. (2011) The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation. J. Inherit. Metab. Dis. 34, 891-899
23. Maydan, G., Noyman, I., Har-Zahav, A., Neriah, Z. B., Pasmanik-Chor, M., Yeheskel, A., Albin-Kaplanski, A., Maya, I., Magal, N., Birk, E., Simon, A. J., Halevy, A., Rechavi, G., Shohat, M., Straussberg, R., and Basel-Vanagaite, L. (2011) Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN. J. Med. Genet. 48, 383-389
24. Muntoni, F., Torelli, S., Wells, D. J., and Brown, S. C. (2011) Muscular dystrophies due to glycosylation defects: Diagnosis and therapeutic strategies. Curr. Opin. Neurol. 24, 437-442
25. Eklund, E. A., and Freeze, H. H. (2006) The congenital disorders of glycosylation: A multifaceted group of syndromes. NeuroRx 3, 254-263 (Pubitemid 44061708)
26. Kumar, P., Henikoff, S., and Ng P. C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081
27. Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., and Sunyaev, S. R. (2010)Amethod and server for predicting damaging missense mutations. Nat. Methods 7, 248-249
28. González-Pérez, A., and López-Bigas, N. (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet. 88, 440-449
29. Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R., and Siepel A. (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20, 110-121
30. Lubke, T., Marquardt, T., Etzioni, A., Hartmann, E., von Figura, K., and Korner, C. (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73-76 (Pubitemid 32405821)
31. Jones, M. A., Ng, B. G., Bhide, S., Chin, E., Rhodenizer, D., He, P., Losfeld, M. E., He, M., Raymond, K., Berry, G., Freeze, H. H., and Hegde, M. R. (2012) DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. Am. J. Hum. Genet. 90, 363-368
32. Kranz, C., Ng, B. G., Sun, L., Sharma, V., Eklund, E. A., Miura, Y., Ungar, D., Lupashin, V., Winkel, R. D., Cipollo, J. F., Costello, C. E., Loh, E., Hong, W., and Freeze, H. H. (2007) COG8 deficiency causes new congenital disorder of glycosylation type IIh. Hum. Mol. Genet. 16, 731-741 (Pubitemid 47061620)
33. Wu, X., Steet, R. A., Bohorov, O., Bakker, J., Newell, J., Krieger, M., Spaapen, L., Kornfeld, S., and Freeze, H. H. (2004) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat. Med. 10, 518-523 (Pubitemid 38667911)
34. Roscioli, T., Kamsteeg, E.-J., Buysse, K., Maystadt, I., van Reeuwijk, J., van den Elzen, C., van Beusekom, E., Riemersma, M., Pfundt, R., Vissers, L. E. L. M., Schraders, M., Altunoglu, U., Buckley, M. F., Brunner, H. G., Grisart, B., Zhou, H., Veltman, J. A., Gilissen, C., Mancini, G. M. S., Delrée, P., Willemsen, M. A., Ramadza, D. P., Chitayat, D., Bennett, C., Sheridan, E., Peeters, E. A. J., Tan-Sindhunata, G. M. B., de Die-Smulders, C. E., Devriendt, K., Kayserili, H., El-Hashash, O. A. E.-F., Stemple, D. L., Lefeber, D. J., Lin, Y.-Y., and van Bokhoven, H. (2012) Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan. Nat. Genet. 44, 581-585
35. Cline, A., Gao, N., Flanagan-Steet, H., Sharma, V., Rosa, S., Sonon, R., Azadi, P., Sadler, K. C., Freeze, H. H., Lehrman, M. A., and Steet, R. (2012) A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism forN-linked glycosylation deficiency. Mol. Biol. Cell 23, 4175-4187
36. Geisler, C., Kotu, V., Sharrow, M., Rendić, D., Poltl, G., Tiemeyer, M., Wilson, I. B., and Jarvis, D. L. (2012) The Drosophila neurally altered carbohydrate mutant has a defective Golgi GDP-fucose transporter. J. Biol. Chem. 287, 29599-29609
37. Freeze, H. H., and Sharma, V. (2010) Metabolic manipulation of glycosylation disorders in humans and animal models. Semin. Cell Dev. Biol. 21, 655-662
38. Schneider, A., Thiel, C., Rindermann, J., DeRossi, C., Popovici, D., Hoffmann, G. F., Grone, H. J., and Korner, C. (2012) Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat. Med. 18, 71-73
39. Grigorian, A., Araujo, L., Naidu, N. N., Place, D. J., Choudhury, B., and Demetriou, M. (2011) N-Acetylglucosamine inhibits T-helper 1 (Th1)/Thelper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis. J. Biol. Chem. 286, 40133-40141
40. Niehues, R., Hasilik, M., Alton, G., Korner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., von Figura, K., Freeze, H. H., Harms, H. K., and Marquardt, T. (1998) Carbohydratedeficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J. Clin. Invest. 101, 1414-1420 (Pubitemid 28166839)
41. Harms, H. K., Zimmer, K. P., Kurnik, K., Bertele-Harms, R. M., Weidinger, S., and Reiter, K. (2002) Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr. 91, 1065-1072 (Pubitemid 35204000)
42. DeRossi, C., Bode, L., Eklund, E. A., Zhang, F., Davis, J. A., Westphal, V., Wang, L., Borowsky, A. D., and Freeze, H. H. (2006) Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accu-mulation, toxicity, and embryonic lethality. J. Biol. Chem. 281, 5916-5927 (Pubitemid 43847692)
43. Thiel, C., Lubke, T., Matthijs, G., von Figura, K., and Korner, C. (2006) Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol. Cell. Biol. 26, 5615-5620 (Pubitemid 44134320)
44. Chu, J., Mir, A., Gao, N., Rosa, S., Monson, C., Sharma, V., Steet, R., Freeze, H. H., Lehrman, M. A., and Sadler, K. C. (2013) A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. Dis. Model. Mech. 6, 95-105
45. Gao, N., Shang, J., Huynh, D., Manthati, V. L., Arias, C., Harding, H. P., Kaufman, R. J., Mohr, I., Ron, D., Falck, J. R., and Lehrman, M. A. (2011) Mannose 6-phosphate regulates destruction of lipid-linked oligosaccharides. Mol. Biol. Cell 22, 2994-3009
46. Gao, N., Shang, J., and Lehrman, M. A. (2005) Analysis of glycosylation in CDG-Ia fibroblasts by fluorophore-assisted carbohydrate electrophoresis. Implications for extracellular glucose and intracellular mannose 6-phosphate. J. Biol. Chem. 280, 17901-17909 (Pubitemid 41389031)
47. Farrugia, M. E. (2011) Myasthenic syndromes. J. R. Coll. Physicians Edinb. 41, 43-47
48. Senderek, J., Müller, J. S., Dusl, M., Strom, T. M., Guergueltcheva, V., Diepolder, I., Laval, S. H., Maxwell, S., Cossins, J., Krause, S., Muelas, N., Vilchez, J. J., Colomer, J., Mallebrera, C. J., Nascimento, A., Nafissi, S., Kariminejad, A., Nilipour, Y., Bozorgmehr, B., Najmabadi, H., Rodolico, C., Sieb, J. P., Steinlein, O. K., Schlotter, B., Schoser, B., Kirschner, J., Herrmann, R., Voit, T., Oldfors, A., Lindbergh, C., Urtizberea, A., von der Hagen, M., Hubner, A., Palace, J., Bushby, K., Straub, V., Beeson, D., Abicht, A., and Lochmuller, H. (2011) Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am. J. Hum. Genet. 88, 162-172
49. Belaya, K., Finlayson, S., Slater, C. R., Cossins, J., Liu, W. W., Maxwell, S., McGowan, S. J., Maslau, S., Twigg, S. R., Walls, T. J., Pascual Pascual, S. I., Palace, J., and Beeson, D. (2012) Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am. J. Hum. Genet. 91, 193-201
50. Carrera, I. A., Matthijs, G., Perez, B., and Cerdá, C. P. (2012) DPAGT1-CDG: Report of a patient with fetal hypokinesia phenotype. Am. J. Med. Genet. A 158A, 2027-2030
51. Hayee, B., Antonopoulos, A., Murphy, E. J., Rahman, F. Z., Sewell, G., Smith, B. N., McCartney, S., Furman, M., Hall, G., Bloom, S. L., Haslam, S. M., Morris, H. R., Boztug, K., Klein, C., Winchester, B., Pick, E., Linch, D. C., Gale, R. E., Smith, A. M., Dell, A., and Segal, A. W. (2011) G6PC3 mutations are associated with a major defect of glycosylation: A novel mechanism for neutrophil dysfunction. Glycobiology 21, 914-924
52. Timal, S., Hoischen, A., Lehle, L., Adamowicz, M., Huijben, K., Sykut-Cegielska, J., Paprocka, J., Jamroz, E., van Spronsen, F. J., Korner, C., Gilissen, C., Rodenburg, R. J., Eidhof, I., Van den Heuvel, L., Thiel, C., Wevers, R. A., Morava, E., Veltman J., and Lefeber, D. J. (2012) Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum. Mol. Genet. 21, 4151-4161
53. Pe'rez, B., Medrano, C., Ecay, M. J., Ruiz-Sala, P., Martínez- Pardo, M., Ugarte, M., and Pe'rez-Cerdá, C. (2013) A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J. Inherit. Metab. Dis., doi 10.1007/s10545-012-9525-7
54. Tang, M., Odejinmi, S. I., Vankayalapati, H., Wierenga, K. J., and Lai, K. (2012) Innovative therapy for classic galactosemia-tale of two HTS. Mol. Genet. Metab. 105, 44-55
55. Pronicka, E., Adamowicz, M., Kowalik, A., Ploski, R., Radomyska, B., Rogaszewska, M., Rokicki, D., and Sykut-Cegielska, J. (2007) Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia. Pediatr. Res. 62, 101-105 (Pubitemid 46985859)
56. Cantagrel, V., and Lefeber, D. J. (2011) From glycosylation disorders to dolichol biosynthesis defects: A new class of metabolic diseases. J. Inherit. Metab. Dis. 34, 859-867
57. Lefeber, D. J., Schonberger, J., Morava, E., Guillard, M., Huyben, K. M., Verrijp, K., Grafakou, O., Evangeliou, A., Preijers, F. W., Manta, P., Yildiz, J., Grunewald, S., Spilioti, M., van den Elzen, C., Klein, D., Hess, D., Ashida, H., Hofsteenge, J., Maeda, Y., van den Heuvel, L., Lammens, M., Lehle, L., and Wevers, R. A. (2009) Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am. J. Hum. Genet. 85, 76-86
58. Ashida, H., Maeda, Y., and Kinoshita, T. (2006) DPM1, the catalytic subunit of dolichol-phosphate mannose synthase, is tethered to and stabilized on the endoplasmic reticulum membrane by DPM3. J. Biol. Chem. 281, 896-904
59. Maeda, Y., Tanaka, S., Hino, J., Kangawa, K., and Kinoshita, T. (2000) Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3. EMBO J. 19, 2475-2482 (Pubitemid 30323537)
60. Barone, R., Aiello, C., Race, V., Morava, E., Foulquier, F., Riemersma, M., Passarelli, C., Concolino, D., Carella, M., Santorelli, F., Vleugels, W., Mercuri, E., Garozzo, D., Sturiale, L., Messina, S., Jaeken, J., Fiumara, A., Wevers, R. A., Bertini, E., Matthijs G., and Lefeber, D. (2012) DPM2-CDG: A muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Ann. Neurol. 72, 550-558
61. Dwyer, C. A., Baker, E., Hu, H., and Matthews, R. T. (2012) RPTP?/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1. Neuroscience 220, 47-61
62. Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A. S., Dobyns, W. B., Winder, T. L., Strahl, S., Mathews, K. D., Nelson, S. F., Moore, S. A., and Campbell, K. P. (2012) ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat. Genet. 44, 575-580
63. Manzini, M. C., Tambunan, D. E., Hill, R. S., Yu, T. W., Maynard, T. M., Heinzen, E. L., Shianna, K. V., Stevens, C. R., Partlow, J. N., Barry, B. J., Rodriguez, J., Gupta, V. A., Al-Qudah, A. K., Eyaid, W. M., Friedman, J. M., Salih, M. A., Clark, R., Moroni, I., Mora, M., Beggs, A. H., Gabriel, S. B., and Walsh, C. A. (2012) Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am. J. Hum. Genet. 91, 541-547
64. Heuston, S., Begley, M., Gahan, C. G., and Hill, C. (2012) Isoprenoid biosynthesis in bacterial pathogens. Microbiology 158, 1389-1401
65. Cantagrel, V., Lefeber, D. J., Ng, B. G., Guan, Z., Silhavy, J. L., Bielas, S. L., Lehle, L., Hombauer, H., Adamowicz, M., Swiezewska, E., De Brouwer, A. P., Blumel, P., Sykut-Cegielska, J., Houliston, S., Swistun, D., Ali, B. R., Dobyns, W. B., Babovic-Vuksanovic, D., van Bokhoven, H., Wevers, R. A., Raetz, C. R., Freeze, H. H., Morava, E., Al-Gazali, L., and Gleeson, J. G. (2010) SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 142, 203-217
66. Stiles, A. R., and Russell, D. W. (2010) SRD5A3: A surprising role in glycosylation. Cell 142, 196-198
67. Zuchner, S., Dallman, J., Wen, R., Beecham, G., Naj, A., Farooq, A., Kohli, M. A., Whitehead, P. L., Hulme, W., Konidari, I., Edwards, Y. J., Cai, G., Peter, I., Seo, D., Buxbaum, J. D., Haines, J. L., Blanton, S., Young, J., Alfonso, E., Vance, J. M., Lam, B. L., and Pericak-Vance, M. A. (2011) Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa. Am. J. Hum. Genet. 88, 201-206
68. Zelinger, L., Banin, E., Obolensky, A., Mizrahi-Meissonnier, L., Beryozkin, A., Bandah-Rozenfeld, D., Frenkel, S., Ben-Yosef, T., Merin, S., Schwartz, S. B., Cideciyan, A. V., Jacobson, S. G., and Sharon, D. (2011) A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews. Am. J. Hum. Genet. 88, 207-215
69. Harrison, K. D., Park, E. J., Gao, N., Kuo, A., Rush, J. S., Waechter, C. J., Lehrman, M. A., and Sessa, W. C. (2011) Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation. EMBO J. 30, 2490-2500
70. Pu, J. J., and Brodsky, R. A. (2011) Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin. Transl. Sci. 4, 219-224
71. Johnston, J. J., Gropman, A. L., Sapp, J. C., Teer, J. K., Martin, J. M., Liu, C. F., Yuan, X., Ye, Z., Cheng, L., Brodsky, R. A., and Biesecker, L. G. (2012) The phenotype of a germline mutation in PIGA: The gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am. J. Hum. Genet. 90, 295-300
72. Maeda, Y., Watanabe, R., Harris, C. L., Hong, Y., Ohishi, K., Kinoshita, K., and Kinoshita, T. (2001) PIG-M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER. EMBO J. 20, 250-261 (Pubitemid 32099121)
73. Almeida, A. M., Murakami, Y., Layton, D. M., Hillmen, P., Sellick, G. S., Maeda, Y., Richards, S., Patterson, S., Kotsianidis, I., Mollica, L., Crawford, D. H., Baker, A., Ferguson, M., Roberts, I., Houlston, R., Kinoshita, T., and Karadimitris, A. (2006) Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat. Med. 12, 846-851 (Pubitemid 44050077)
74. Almeida, A. M., Murakami, Y., Baker, A., Maeda, Y., Roberts, I. A., Kinoshita, T., Layton, D. M., and Karadimitris, A. (2007) Targeted therapy for inherited GPI deficiency. N. Engl. J. Med. 356, 1641-1647 (Pubitemid 46631673)
75. Krawitz, P. M., Schweiger, M. R., Rodelsperger, C., Marcelis, C., Kolsch, U., Meisel, C., Stephani, F., Kinoshita, T., Murakami, Y., Bauer, S., Isau, M., Fischer, A., Dahl, A., Kerick, M., Hecht, J., Kohler, S., Jager, M., Grunhagen, J., de Condor, B. J., Doelken, S., Brunner, H. G., Meinecke, P., Passarge, E., Thompson, M. D., Cole, D. E., Horn, D., Roscioli, T., Mundlos, S., and Robinson, P. N. (2010) Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat. Genet. 42, 827-829
76. Krawitz, P. M., Murakami, Y., Hecht, J., Kruger, U., Holder, S. E., Mortier, G. R., Delle Chiaie, B., De Baere, E., Thompson, M. D., Roscioli, T., Kielbasa, S., Kinoshita, T., Mundlos, S., Robinson, P. N., and Horn, D. (2012) Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am. J. Hum. Genet. 91, 146-151
77. Murakami, Y., Kanzawa, N., Saito, K., Krawitz, P. M., Mundlos, S., Robinson, P. N., Karadimitris, A., Maeda, Y., and Kinoshita, T. (2012) Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome. J. Biol. Chem. 287, 6318-6325
78. Foulquier, F., Amyere, M., Jaeken, J., Zeevaert, R., Schollen, E., Race, V., Bammens, R., Morelle, W., Rosnoblet, C., Legrand, D., Demaegd, D., Buist, N., Cheillan, D., Guffon, N., Morsomme, P., Annaert, W., Freeze, H. H., Van Schaftingen, E., Vikkula, M., and Matthijs, G. (2012) TMEM165 deficiency causes a congenital disorder of glycosylation. Am. J. Hum. Genet. 91, 15-26
79. Cao, S. S., and Kaufman, R. J. (2012) Unfolded protein response. Curr. Biol. 22, R622-R626
80. Shang, J., Korner, C., Freeze, H., and Lehrman, M. A. (2002) Extension of lipid-linked oligosaccharides is a high-priority aspect of the unfolded protein response: Endoplasmic reticulum stress in type I congenital disorder of glycosylation fibroblasts. Glycobiology 12, 307-317 (Pubitemid 34812049)
81. Need, A. C., Shashi, V., Hitomi, Y., Schoch, K., Shianna, K. V., McDonald, M. T., Meisler, M. H., and Goldstein, D. B. (2012) Clinical application of exome sequencing in undiagnosed genetic conditions. J. Med. Genet. 49, 353-361
82. Rafiq, M. A., Kuss, A. W., Puettmann, L., Noor, A., Ramiah, A., Ali, G., Hu, H., Kerio, N. A., Xiang, Y., Garshasbi, M., Khan, M. A., Ishak, G. E., Weksberg, R., Ullmann, R., Tzschach, A., Kahrizi, K., Mahmood, K., Naeem, F., Ayub, M., Moremen, K. W., Vincent, J. B., Ropers, H. H., Ansar, M., and Najmabadi, H. (2011) Mutations in the α1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am. J. Hum. Genet. 89, 176-182